Company name

TOKIWA Pharmaceutical Co., Ltd.

Address

Sumitomo Seimei Honmachi Bldg.9F, 3-5-12 Azuchi-machi,
Chuo-ku, Osaka, Japan

Date of Establishment

October, 1946

Date of Incorporation

March, 1949

Capital

4,301,265 thousand Japanese Yen
[Shareholders]
Noevir Holdings Co., Ltd.
100%

Director

President and Representative Director
Masataka Nakano

No.Of Employees

As of January 1, 2012
Non-consolidated ： 760（male:510, female:250）
Consolidated ： 1,037（male:747, female:290）
* Directors/corporate officers, advisors, and part-time/temporary
staff are excluded

Lines of Business

Tokiwa develops, manufactures and markets pharmaceuticals, quasi-drugs, cosmetics and health food products.

Offices

[Headquarters] Tokyo, Osaka and Kobe
[Location of Offices] Sapporo, Sendai, Saitama, Tokyo, Nagoya, Osaka, Hiroshima, Takamatsu and Fukuoka.
[Location of R&D/Factory] Mie

Affiliated company

Tokiwa Medical Service Co., Ltd.

March, 1949

Incorporated TOKIWA Pharmaceutical Co.,Ltd.

November, 1985

NOV Co., Ltd. business initiated

June, 1986

Incorporated SANA Co., Ltd.

September, 2002

Tokiwa Pharmaceutical became a subsidiary of Noevir Co., Ltd.

September, 2004

Three subsidiary companies, Tokiwa Pharmaceutical, NOV and SANA,
under Noevir Co., Ltd. merged as part of its subsidiary reorganization

June, 2011

Tokiwa Pharmaceutical was transferred to become a subsidiary of Noevir Holdings Co., Ltd. from Noevir Co., Ltd. in reorganization.